Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

ALL in young adults: unique challenges, improving outcomes, and advice for community oncologists

VJHemOnc is pleased to share a feature article that explores ALL in young adult patients.

Read More

Updates in CMML – consensus guidelines, promising therapeutic approaches, the implications of TP53 expression, and more

VJHemOnc is pleased to share a feature article highlighting updates in CMML.

Read More

VEXAS syndrome and MDS: exploring biology, challenges, and treatment

VJHemOnc is pleased to share a feature article that explores the biology and challenges of VEXAS syndrome.

Read More

Moving beyond JAK inhibition in myelofibrosis – options being explored

VJHemOnc is thrilled to bring you a feature article highlighting options being explored for the treatment of myelofibrosis beyond JAK…

Read More

Practical considerations for GPRC5D-directed therapies in multiple myeloma

Read More

An insight into the biology of MDS in younger adults: a unique clinical challenge

VJHemOnc is pleased to share a feature article that explores the biology of MDS in younger adults – a rare,…

Read More

A deep dive into rare diseases: cutaneous T-cell lymphoma

This article delves into cutaneous T-cell lymphoma (CTCL), covering the diagnosis, standard of care, and future treatment directions. What is…

Read More

Latest advances in time-limited BTK and BCL2 inhibitor combinations for the frontline treatment of CLL

“So from this year’s ASH I’m really most excited about the AMPLIFY Phase III trial. This is likely going to…

Read More

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals